Objective: We investigated the association between socioeconomic factors and the attainment of treatment goals and pharmacotherapy in patients with type 2 diabetes in Denmark. Design: A cross-sectional population study. Setting: The municipality of Naestved, Denmark. Subjects: We studied 907 patients with type 2 diabetes identified from a random sample of 21,205 Danish citizens. Main outcome measures: The proportion of patients who were not achieving goals for diabetes care based on their HbA1c, LDL-cholesterol, blood pressure, and lifestyle, and the proportion of patients who were treated with antihypertensive and cholesterol- and glucose-lowering medication. Methods: We investigated the association of the socioeconomic factors such as age...
Introduction Quality of care could be influenced by individual socio-economic status (SES) and by re...
Abstract Understanding socioeconomic inequalities in health care is critical for achieving health eq...
AIMS: To assess any disparities in the initiation of second-line antidiabetic treatments prescribed ...
BACKGROUND: Few large-scale studies have examined the association between sociodemographic factors a...
BACKGROUND: Concurrent multifactorial treatment is needed to reduce consequent risks of diabetes, ye...
To assess the association of socioeconomic position with health (care) outcomes in type 2 diabetes w...
Objective Investigating demographic and socioeconomic factors as intersecting rather than as separat...
Objective Investigating demographic and socioeconomic factors as intersecting rather than as separat...
Specific aims: To examine whether the sociodemographic characteristics of patients with type 2 diabe...
Background: Socioeconomic status, origin or demographic attributes shall not determine the quality o...
BACKGROUND:Socioeconomic status, origin or demographic attributes shall not determine the quality of...
The major increase in the prevalence of diabetes mellitus (DM) has led to the study of social inequa...
<div><p>Background</p><p>Socioeconomic status, origin or demographic attributes shall not determine ...
OBJECTIVE: To evaluate socioeconomic disadvantage in prevalence, awareness and control of diabetes i...
Demographic changes and the increased chronical diseases burden are global challenges that cannot go...
Introduction Quality of care could be influenced by individual socio-economic status (SES) and by re...
Abstract Understanding socioeconomic inequalities in health care is critical for achieving health eq...
AIMS: To assess any disparities in the initiation of second-line antidiabetic treatments prescribed ...
BACKGROUND: Few large-scale studies have examined the association between sociodemographic factors a...
BACKGROUND: Concurrent multifactorial treatment is needed to reduce consequent risks of diabetes, ye...
To assess the association of socioeconomic position with health (care) outcomes in type 2 diabetes w...
Objective Investigating demographic and socioeconomic factors as intersecting rather than as separat...
Objective Investigating demographic and socioeconomic factors as intersecting rather than as separat...
Specific aims: To examine whether the sociodemographic characteristics of patients with type 2 diabe...
Background: Socioeconomic status, origin or demographic attributes shall not determine the quality o...
BACKGROUND:Socioeconomic status, origin or demographic attributes shall not determine the quality of...
The major increase in the prevalence of diabetes mellitus (DM) has led to the study of social inequa...
<div><p>Background</p><p>Socioeconomic status, origin or demographic attributes shall not determine ...
OBJECTIVE: To evaluate socioeconomic disadvantage in prevalence, awareness and control of diabetes i...
Demographic changes and the increased chronical diseases burden are global challenges that cannot go...
Introduction Quality of care could be influenced by individual socio-economic status (SES) and by re...
Abstract Understanding socioeconomic inequalities in health care is critical for achieving health eq...
AIMS: To assess any disparities in the initiation of second-line antidiabetic treatments prescribed ...